PERCEIVE BIO

Serial Number 97604161
Registration 7211505
700

Registration Progress

Application Filed
Sep 23, 2022
Under Examination
Approved for Publication
Aug 22, 2023
Published for Opposition
Aug 22, 2023
Registered
Nov 7, 2023

Trademark Image

PERCEIVE BIO

Basic Information

Serial Number
97604161
Registration Number
7211505
Filing Date
September 23, 2022
Registration Date
November 7, 2023
Published for Opposition
August 22, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 7, 2023
Registration
Registered
Classes
042

Rights Holder

Perceive Biotherapeutics, Inc.

03
Address
6000 SHORELINE CT., STE. 206
South San Francisco, CA 94080

Ownership History

Perceive Biotherapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Perceive Biotherapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Perceive Biotherapeutics, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
J. Dickson Phillips, III

USPTO Deadlines

Next Deadline
1415 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231107)
Due Date
November 07, 2029
Grace Period Ends
May 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Nov 7, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 7, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 22, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 22, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 2, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 17, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 12, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 12, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 12, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 12, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 27, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; pharmaceutical research and development in the field of therapeutics for improving neuronal survival in neurodegenerative diseases; Providing medical and scientific research information; Providing medical and scientific research information in the fields of therapeutics for improving neuronal survival in neurodegenerative diseases
First Use Anywhere: May 18, 2022
First Use in Commerce: May 18, 2022

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIO